Correction to: Poor correlation between preclinical and patient efficacy data for tumor targeted monotherapies in glioblastoma: the results of a systematic review

Ashray Gunjur; Adithya Balasubramanian; Umbreen Hafeez; Siddharth Menon; Lawrence Cher; Sagun Parakh; Hui Kong Gan

doi:10.1007/s11060-022-04119-z

Correction to: Poor correlation between preclinical and patient efficacy data for tumor targeted monotherapies in glioblastoma: the results of a systematic review

J Neurooncol. 2022 Sep;159(3):551. doi: 10.1007/s11060-022-04119-z.

Authors

Ashray Gunjur^{1

2}, Adithya Balasubramanian^{2

3}, Umbreen Hafeez^{2

4

5

6}, Siddharth Menon^{2

4

5}, Lawrence Cher², Sagun Parakh^{2

4

5}, Hui Kong Gan^{7

8

9

10}

Affiliations

¹ Experimental Cancer Genetics, Wellcome Sanger Institute, Hinxton, UK.
² Department of Medical Oncology, Austin Health, 145 Studley Road, Heidelberg, VIC, 3084, Australia.
³ Personalised Oncology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, 3052, Australia.
⁴ Olivia Newton-John Cancer Research Institute, Austin Hospital, 145 Studley Road, Heidelberg, VIC, 3084, Australia.
⁵ La Trobe University School of Cancer Medicine, 145 Studley Road, Heidelberg, VIC, 3084, Australia.
⁶ Medical Student Education, University of Melbourne, Gratton St, Parkville, VIC, 3010, Australia.
⁷ Department of Medical Oncology, Austin Health, 145 Studley Road, Heidelberg, VIC, 3084, Australia. hui.gan@onjcri.org.au.
⁸ Olivia Newton-John Cancer Research Institute, Austin Hospital, 145 Studley Road, Heidelberg, VIC, 3084, Australia. hui.gan@onjcri.org.au.
⁹ La Trobe University School of Cancer Medicine, 145 Studley Road, Heidelberg, VIC, 3084, Australia. hui.gan@onjcri.org.au.
¹⁰ Department of Medicine, University of Melbourne, 145 Studley Road, Heidelberg, VIC, 3084, Australia. hui.gan@onjcri.org.au.

PMID: 35994157
DOI: 10.1007/s11060-022-04119-z

No abstract available

Publication types

Published Erratum